Sheaff Brock Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $677K | Buy |
2,175
+241
| +12% | +$71.2K | 0.06% | 223 |
|
|
2024
Q4 | $504K | Buy |
1,934
+100
| +5% | +$29.7K | 0.04% | 254 |
|
|
2024
Q3 | $591K | Sell |
1,834
-3
| -0.2% | -$981 | 0.05% | 236 |
|
|
2024
Q2 | $574K | Sell |
1,837
-1,236
| -40% | -$363K | 0.05% | 228 |
|
|
2024
Q1 | $874K | Buy |
3,073
+1
| +0% | +$293 | 0.06% | 207 |
|
|
2023
Q4 | $885K | Sell |
3,072
-13
| -0.4% | -$3.54K | 0.07% | 195 |
|
|
2023
Q3 | $829K | Buy |
3,085
+7
| +0.2% | +$1.75K | 0.08% | 182 |
|
|
2023
Q2 | $683K | Sell |
3,078
-13,690
| -82% | -$3.18M | 0.06% | 212 |
|
|
2023
Q1 | $4.05M | Buy |
16,768
+559
| +3% | +$137K | 0.37% | 57 |
|
|
2022
Q4 | $4.26M | Buy |
16,209
+12,477
| +334% | +$3.34M | 0.42% | 55 |
|
|
2022
Q3 | $841K | Buy |
3,732
+32
| +0.9% | +$7.76K | 0.09% | 174 |
|
|
2022
Q2 | $900K | Buy |
3,700
+30
| +0.8% | +$7.35K | 0.08% | 171 |
|
|
2022
Q1 | $888K | Buy |
3,670
+41
| +1% | +$9.42K | 0.06% | 194 |
|
|
2021
Q4 | $816K | Sell |
3,629
-277
| -7% | -$58.5K | 0.05% | 206 |
|
|
2021
Q3 | $831K | Sell |
3,906
-54
| -1% | -$12.4K | 0.06% | 196 |
|
|
2021
Q2 | $965K | Sell |
3,960
-12,239
| -76% | -$3.01M | 0.07% | 180 |
|
|
2021
Q1 | $4.03M | Sell |
16,199
-17,002
| -51% | -$4.06M | 0.32% | 61 |
|
|
2020
Q4 | $7.63M | Buy |
33,201
+12,254
| +59% | +$2.83M | 0.64% | 25 |
|
|
2020
Q3 | $5.32M | Sell |
20,947
-95
| -0.5% | -$23.5K | 0.49% | 33 |
|
|
2020
Q2 | $4.96M | Sell |
21,042
-11,335
| -35% | -$2.59M | 0.49% | 34 |
|
|
2020
Q1 | $6.56M | Sell |
32,377
-2,987
| -8% | -$652K | 0.87% | 17 |
|
|
2019
Q4 | $8.53M | Sell |
35,364
-246
| -0.7% | -$54.2K | 0.83% | 20 |
|
|
2019
Q3 | $6.89M | Sell |
35,610
-1,548
| -4% | -$297K | 0.75% | 23 |
|
|
2019
Q2 | $6.85M | Buy |
37,158
+22
| +0.1% | +$3.94K | 0.74% | 23 |
|
|
2019
Q1 | $7.05M | Sell |
37,136
-718
| -2% | -$137K | 0.86% | 21 |
|
|
2018
Q4 | $7.37M | Buy |
37,854
+1,488
| +4% | +$290K | 1.16% | 16 |
|
|
2018
Q3 | $7.54M | Sell |
36,366
-4,489
| -11% | -$885K | 0.71% | 24 |
|
|
2018
Q2 | $7.54M | Buy |
40,855
+243
| +0.6% | +$43K | 0.74% | 25 |
|
|
2018
Q1 | $6.92M | Sell |
40,612
-2,487
| -6% | -$457K | 0.72% | 24 |
|
|
2017
Q4 | $7.5M | Buy |
43,099
+6,753
| +19% | +$1.2M | 0.97% | 22 |
|
|
2017
Q3 | $6.78M | Sell |
36,346
-5,368
| -13% | -$951K | 0.89% | 22 |
|
|
2017
Q2 | $7.18M | Sell |
41,714
-4
| -0% | -$651 | 0.95% | 20 |
|
|
2017
Q1 | $6.84M | Sell |
41,718
-325
| -0.8% | -$54K | 0.89% | 22 |
|
|
2016
Q4 | $6.15M | Sell |
42,043
-849
| -2% | -$128K | 0.78% | 29 |
|
|
2016
Q3 | $7.16M | Sell |
42,892
-6,628
| -13% | -$1.12M | 0.96% | 20 |
|
|
2016
Q2 | $7.53M | Sell |
49,520
-3,121
| -6% | -$485K | 0.96% | 19 |
|
|
2016
Q1 | $7.89M | Sell |
52,641
-5,303
| -9% | -$788K | 0.97% | 19 |
|
|
2015
Q4 | $9.41M | Buy |
+57,944
| New | +$9.11M | 1.07% | 16 |
|
Other funds holding AMGN
Sheaff Brock Investment Advisors's AMGN Position: Q1 2025 in Review
Sheaff Brock Investment Advisors increased its Amgen (AMGN) stake by 12% in Q1 2025, buying an estimated $71.2K and bringing the position to 2,175 shares worth $677K. The position accounts for 0.06% of the portfolio, ranked #223.
Sheaff Brock Investment Advisors first reported a position in AMGN in Q4 2015 and has held it in 38 quarters since. The position peaked at $9.41M in Q4 2015. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Sheaff Brock Investment Advisors held 2,175 shares of Amgen worth $677K as of Q1 2025.
- Sheaff Brock Investment Advisors bought 241 Amgen shares in Q1 2025, an estimated $71.2K.
- Amgen made up 0.06% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #223 holding.
- Sheaff Brock Investment Advisors first reported a position in Amgen in Q4 2015 and has held it in 38 quarters since.
- Sheaff Brock Investment Advisors's Amgen position peaked at $9.41M in Q4 2015.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.